SR One portfolio
34 tracked investments, 7 on the map, $1.8B raised across the mapped portfolio.
- CRISPR TherapeuticsPost-IPO Equity
- Mineralys Therapeutics
- ARS Pharmaceuticals OperationsSeries D
- Nomic BioSeries B
- ADARx PharmaceuticalsSeries C
- Principia Biopharma
- CORXEL Pharmaceuticals
Also in the portfolio
- Nimbus Therapeutics
- Avenzo Therapeutics
- CHARM Therapeutics
- Fore Biotherapeutics
- Dren Bio
- Progyny
- ORIC Pharmaceuticals
- Simcha Therapeutics
- KALA BIO
- Pulmocide
- Propeller Health
- Ancora Biotech
- ZappRx
- AGTC
- Morphic Therapeutic
- Bird Rock Bio
- Pandion Therapeutics
- F-Star Therapeutics
- HTG Molecular Diagnostics
- Translate Bio
- Turning Point Therapeutics
- IlluminOss Medical
- MicroMass Communications
- iPierian
- POINT Biomedical
- Protein Forest
- Xenogen Corporation